Goodwin Procter acted as legal counsel to BridgeBio Oncology Therapeutics, while White & Case acted as legal counsel to Helix Acquisition Corp. II on the transaction....
Helix Acquisition Corp. II’s US$949 Million Business Combination with BridgeBio Oncology Therapeutics
LENZ Therapeutics’ Merger with Graphite Bio
Wilson Sonsini Goodrich & Rosati is representing LENZ Therapeutics in the transaction, Goodwin Procter is representing Graphite Bio and Latham & Watkins is representing the placements...
JMI Equity’s $85 Million Investment in ServiceTrade
Goodwin Procter advised JMI Equity on the deal. JMI Equity announced its $85 million growth investment in ServiceTrade. With the additional capital, ServiceTrade will increase the pace...
Enfusion’s $367 Million IPO
Goodwin advised Enfusion on the deal, while Davis Polk advised the representatives of the several underwriters. Enfusion, Inc. completed its initial public offering of 21,562,500 shares...
Synaptics Incorporated’s Acquisition of DSP Group
Goodwin Procter advised Synaptics Incorporated on the deal while Morrison & Foerster represented DSP Group, Inc. Synaptics Incorporated (Nasdaq: SYNA) and DSP Group, Inc. (Nasdaq: DSPG)...